Axel Bolte Email & Phone
Co-Founder
- Inozyme Pharma
| Boston, MA, US
Axel Bolte Email Addresses
ax********@gmail.com
ax********@me.com
a********@me.com
b****@inozyme.com
Axel Bolte Phone Numbers
41******818
21*****365
90*******000
+4**********994
5 free credits per month
Get more credits at $24 USD/month
Axel Bolte Work
Co-Founder @ Inozyme Pharma
Investment Advisor @ HBM Partners AG
Chief Executive Officer @ Inozyme Pharma
Director @ Burka Coffee Estates Ltd.
Director @ Mondul Coffee Estates Ltd.
Co-Founder @ Turos Capital AG
Director @ IVERIC bio
Managing Member @ Tripex Pharmaceuticals LLC
Venture Partner @ HBM Partners AG
Board Member @ Allena Pharmaceuticals, Inc.
Director @ Nabriva Therapeutics plc
Director @ Ophthotech Corp
Board Observer @ AnaptysBio
Vice Chairman of the Board @ Kolltan Pharmaceuticals, Inc.
Director @ PTC Therapeutics (PTCT)
US Investment Advisor to HBM Partners @ The Trout Group
Board Observer @ Enanta Pharmaceuticals
Director @ Mpex Pharmaceuticals
Investment Advisor @ HBM Partners AG
Director @ Newron Pharmaceuticals Spa
Axel Bolte Education
1998 - 2000 Master of Business Administration @ University of St. Gallen
1991 - 1996 @ Eidgenössische Technische Hochschule Zürich
Axel Bolte Skills
Investments, Customer Service, Strategic Planning, Microsoft Excel, Strategy, Financial Analysis, Business Strategy, Leadership, Venture Capital, Interim Management, Investment Advisory, Corporate Finance, Real Estate, Executive Pay, Clinical Trials, CRO, Executive Management, Chemistry, Valuation, Infectious Diseases, Start Ups, Clinical Research, Biotechnology, Regulatory Affairs, Negotiation, Immunology, Life Sciences, Medical Devices, Ophthalmology, Licensing, M&A execution, Drug Discovery, Molecular Biology, Lifesciences, Oncology, Drug Development, Clinical Development, Executive Compensation, Vaccines, Orphan Drugs, Pharmacology, Medicinal Chemistry, M&A experience, Private Equity, Due Diligence, Pharmaceutical Industry, Technology Transfer, IPO, Corporate Development, Mergers and Acquisitions, R&d, Commercialization, Venture Financing, Biopharmaceuticals
Axel Bolte Summary
Axel Bolte, based in Boston, MA, US, is currently a Co-Founder at Inozyme Pharma. Axel Bolte brings experience from previous roles at HBM Partners AG, Inozyme Pharma, Burka Coffee Estates Ltd., Mondul Coffee Estates Ltd., Turos Capital AG, IVERIC bio, Tripex Pharmaceuticals LLC, HBM Partners AG, Allena Pharmaceuticals, Inc., Nabriva Therapeutics plc, Ophthotech Corp, AnaptysBio, Kolltan Pharmaceuticals, Inc., PTC Therapeutics (PTCT), The Trout Group, Enanta Pharmaceuticals, Mpex Pharmaceuticals, HBM Partners AG, Newron Pharmaceuticals Spa. Axel Bolte holds various educational qualifications including Master of Business Administration in Economics (1998 - 2000) from University of St. Gallen. With a robust skill set that includes Investments, Customer Service, Strategic Planning, Microsoft Excel, Strategy, Axel Bolte demonstrates proficiency in a wide range of areas.
Frequently Asked Questions about Axel Bolte
What is Axel Bolte phone number?
Axel Bolte phone number is 91*******372.
How to contact Axel Bolte?
To contact Axel Bolte, send an email to ax********@inozyme.com or call 91*******372.
What company does Axel Bolte work for?
Axel Bolte works for Inozyme Pharma.
What is Axel Bolte's current role at Inozyme Pharma?
Axel Bolte is Co-Founder at Inozyme Pharma.
Where is Axel Bolte located?
Axel Bolte is based in Boston, MA, US.
Axel Bolte Email Addresses
ax********@gmail.com
ax********@me.com
a********@me.com
b****@inozyme.com
Axel Bolte Phone Numbers
41******818
21*****365
90*******000
+4**********994
5 free credits per month
Get more credits at $24 USD/month
Looking for different Axel Bolte?
People with Skills like Axel Bolte?
People in Roles like Axel Bolte?
Get Started with Saleshandy
Book More Meetings
Find decision-makers, personalize outreach, and get more meetings booked effortlessly.
Generate More Leads
Automate follow-ups, increase replies, and consistently fill your sales pipeline with qualified leads.
Close More Deals
Track engagement, optimize campaigns, and convert cold prospects into paying customers faster.